Calendar Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse 04:00:02 2024-04-22 pm EDT 5-day change 1st Jan Change
83.62 USD +2.93% Intraday chart for Haemonetics Corporation -1.48% -2.21%

Chart calendar Haemonetics Corporation

d7a528.xeuprSWvK4EqiSzkfzFJAFULn3BG2Z-xBrZhvOWM9Mo.vdrn_mnOZrdPu1S8J358WDly6wMxgKbwT-Q4j6TTluexuYTLXcpps2_DHA~f2cc5214a8410a172e62102f165df627

Upcoming events on Haemonetics Corporation

2024-05-09 06:00 am Q4 2024 Earnings Release
2024-05-09 08:00 am Q4 2024 Earnings Call
2024-08-05 Q1 2025 Earnings Release (Projected)
2024-11-04 Q2 2025 Earnings Release (Projected)
2025-02-10 Q3 2025 Earnings Release (Projected)
2025-05-12 Q4 2025 Earnings Release (Projected)

Past events on Haemonetics Corporation

2024-03-05 07:30 am Raymond James Institutional Investors Conference
2024-02-29 08:45 am Citi Unplugged Medtech and Life Sciences Access Day
2024-02-08 08:00 am Q3 2024 Earnings Call
2024-02-08 06:00 am Q3 2024 Earnings Release
2024-01-09 12:45 pm JPMorgan Healthcare Conference
2023-11-02 08:00 am Q2 2024 Earnings Call
2023-11-02 06:00 am Q2 2024 Earnings Release
2023-09-13 Barrington Virtual Fall Investor Conference
2023-08-08 08:00 am Q1 2024 Earnings Call
2023-08-08 06:00 am Q1 2024 Earnings Release
2023-08-04 08:00 am Annual General Meeting
2023-05-11 08:00 am Q4 2023 Earnings Call
2023-05-11 06:00 am Q4 2023 Earnings Release
2023-03-06 08:40 am Raymond James Institutional Investors Conference
2023-02-07 08:00 am Q3 2023 Earnings Call
2023-02-07 06:00 am Q3 2023 Earnings Release
2023-01-10 05:15 pm JP Morgan Healthcare Conference
2022-11-07 08:00 am Interim 2023 Earnings Call
2022-11-07 06:00 am Interim 2023 Earnings Release
2022-09-12 08:45 am Morgan Stanley Global Healthcare Conference

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
968
968
-0.09%
988
996
-0.74%
870
869
0.18%
993
986
0.71%
1 169
1 155
1.19%

1 295

EBITDA
Million USD
Released
Forecast
Spread
248
257
-3.46%
307
324
-5.25%
239
246
-3.05%
285
268
6.1%
305
301
1.3%

358

EBIT
Million USD
Released
Forecast
Spread
165
162
1.65%
218
221
-1.24%
155
169
-8.54%
187
184
1.6%
218
215
1.57%

275

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
73,6
83,7
-12.03%
87,2
95,2
-8.48%
72,9
121
-39.58%
63,6
59,0
7.77%
141
141
0.13%

170

Net income
Million USD
Released
Forecast
Spread
55,0
52,6
4.67%
76,5
84,2
-9.14%
79,5
113
-29.52%
43,4
42,5
1.94%
115
106
8.7%

126

EPS
USD
Released
Forecast
Spread
1,04
1,17
-10.73%
1,48
1,62
-8.83%
1,55
2,24
-30.73%
0,84
0,95
-11.58%
2,24
2,12
5.49%

2,50

Announcement Date07/05/1905/05/2013/05/2110/05/2211/05/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
260
265
-2.12%
265
257
3.07%
261
249
5%
297
269
10.5%
305
300
1.61%
304
291
4.69%
311
293
6.37%
318
313
1.62%
336
321
4.82%

329


329


340


357


340

EBITDA
Million USD
Released
Forecast
Spread
71,0
65,9
7.79%
71,4
62,0
15.15%
64,3
56,3
14.06%
67,7
69,8
-2.99%
82,0
80,3
2.1%
76,9
74,1
3.75%
92,8
72,2
28.58%
90,8
83,6
8.65%
96,9
81,7
18.62%

84,9


96,4


99,3


102


97,1

EBIT
Million USD
Released
Forecast
Spread
58,8
52,3
12.44%
46,6
43,8
6.27%
44,9
38,6
16.3%
60,6
48,9
23.89%
59,0
60,7
-2.72%
53,9
51,2
5.36%
70,2
54,6
28.7%
68,3
64,4
6.08%
73,4
67,3
9.09%

63,5


73,5


76,4


81,1


76,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
31,4
14,2
121.15%
15,3
10,7
42.7%
25,5
8,34
205.83%
41,1
30,9
33.05%
42,2
38,1
10.81%
32,6
32,4
0.55%
51,6
29,9
72.78%
32,8
47,4
-30.78%
44,0
47,2
-6.73%

41,8


52,4


55,8


57,9


53,8

Net income
Million USD
Released
Forecast
Spread
23,2
14,9
55.5%
9,74
8,92
9.27%
19,9
6,92
187.28%
33,2
18,7
77.19%
32,9
27,9
18.24%
29,4
20,2
45.79%
41,0
21,0
95.48%
24,9
31,4
-20.7%
31,2
31,7
-1.52%

28,6


35,6


38,9


42,8


41,0

EPS
USD
Released
Forecast
Spread
0,45
0,39
15.38%
0,19
0,30
-35.59%
0,38
0,22
72.73%
0,64
0,41
57.38%
0,64
0,57
12.28%
0,57
0,45
26.67%
0,80
0,52
54.84%
0,48
0,69
-30.43%
0,61
0,70
-12.86%

0,60


0,76


0,81


0,90


0,84

Announcement Date08/02/2210/05/2210/08/2207/11/2207/02/2311/05/2308/08/2302/11/2308/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HAE Stock
  4. Calendar Haemonetics Corporation